Research

European Commission calls on interested parties to submit information on biocides

The Commission has requested the advice of the Scientific Committee on Emerging and Newly Identified Health risks (SCENIHR) on the assessment of the antibiotic resistance effects of biocides. To ensure that the SCENIHR formulates its views on the basis of the most complete relevant information, the Commission has published a call for the submission of information regarding quantities of biocides used in various applications and regarding possible changes in microbial flora.

Call for papers accelerates cancer information transfer - ecancermedicalscience

ecancermedicalscience aims to improve communications between sub-specialised cancer scientists and clinicians by working interactively and faster - offering authors a rapid peer review process. Submit your paper and you'll hear if it will be published within three weeks.

Nature Publishing Group and Sermo partner to help physicians

Nature Publishing Group (NPG) and Sermo, the largest online physician community in the US, announced a partnership to facilitate the discussion and interpretation of content in leading NPG medical journals by US physicians.

New Online Social Network, BioMedExperts, to Improve Collaboration Among Medical Researchers

Collexis Holdings, Inc. (OTCBB: CLXS), a leading developer of high definition search and knowledge discovery software, announced the debut of BioMedExperts - the first online social network of its kind to improve collaboration among researchers and therefore advance medical science. Collexis launched the new service with more than 1.4 million pre-generated profiles of its expected users from across 120 countries and expects to grow by another two million profiles over the next few months.

EU Pharmacovigilance Strategy: Public consultation on draft legislative proposals

DG Enterprise and Industry wishes to consult stakeholders on legislative proposals to strengthen and rationalise the EU system of pharmacovigilance. The Commission services conducted a previous consultation, between 16 March 2006 and 12 May 2006, which sought stakeholders' views on the strengths and weaknesses of the current EU system of pharmacovigilance and how the system could be strengthened.

The Largest Pharmaceutical Companies and Britain's Serious Fraud Office in the News

Oil-for-food: UK probe to cover more companies
A UK government probe into whether GlaxoSmithKline, AstraZeneca and Eli Lilly & Co bribed the Saddam Hussein administration in Iraq may expand to other...

British ask Lilly for data on Iraq sales
British fraud investigators are questioning Eli Lilly and Co. and at least two other drug makers about possible kickbacks they paid to trade...

UK pulls Glaxo into Iraq fraud probe
Serious Fraud Office has requested documents from GlaxoSmithKline as part of an investigation into kickbacks or bribes that may have...

Transinsight's GoPubMed with Social Networking Features for Biomedical Experts

Biomedical research happens in networks of researchers. Social networking web sites like FaceBook, LinkedIn and Xing use personal networks to establish contacts. On these sites, however, connections must be defined by the users themselves. For the first time, GoPubMed now completely and automatically extracts collaboration networks from millions of biomedical science publications.

European Commission calls on interested parties to submit information on biocides

Call for papers accelerates cancer information transfer - ecancermedicalscience

Nature Publishing Group and Sermo partner to help physicians

New Online Social Network, BioMedExperts, to Improve Collaboration Among Medical Researchers

EU Pharmacovigilance Strategy: Public consultation on draft legislative proposals

The Largest Pharmaceutical Companies and Britain's Serious Fraud Office in the News

Transinsight's GoPubMed with Social Networking Features for Biomedical Experts

More Pharma News ...

Business & Industry

Research & Development

Conferences & Events

Regulatory Affairs